SciVision Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	915.86	845.81	706.02	511.1	587.02	658.92
Short-Term Investments	-	79.9	99.9	233.9	30.71	36.92
Trading Asset Securities	176.58	-	-	-	-	-
Cash & Short-Term Investments	1,092	925.71	805.92	745	617.73	695.84
Cash Growth	21.50%	14.86%	8.18%	20.60%	-11.23%	68.36%
Accounts Receivable	288.03	242.14	172.94	95.18	90.34	78.37
Other Receivables	3.15	1.56	1.09	1.02	1.16	0.2
Receivables	291.17	243.7	174.02	96.21	91.49	78.56
Inventory	99.36	82.15	72.23	87.25	95.87	82.9
Prepaid Expenses	43.4	46.39	47.94	15.48	18.65	21.7
Other Current Assets	0.55	129.23	66.3	59.97	57.29	46.24
Total Current Assets	1,527	1,427	1,166	1,004	881.03	925.24
Property, Plant & Equipment	1,213	1,228	1,176	1,135	1,184	1,246
Other Intangible Assets	1.59	1.4	1.68	2.15	2.67	3.38
Long-Term Deferred Tax Assets	3.79	7.14	5.02	15.5	25.04	31.33
Other Long-Term Assets	6.2	6.2	5.01	3.22	5.23	56.48
Total Assets	2,751	2,670	2,354	2,160	2,098	2,262
Accounts Payable	23.43	16.4	13.27	6.75	14.02	5.46
Accrued Expenses	-	113.91	135.76	102.56	78.4	-
Short-Term Debt	-	0.51	-	-	-	-
Current Portion of Long-Term Debt	-	-	134.79	-	-	303.37
Current Portion of Leases	10.22	10.18	4.73	1.22	1.2	1.24
Current Income Taxes Payable	8.41	2.39	12.65	5.77	13.97	-
Current Unearned Revenue	2.48	1.55	2.68	7.02	0.7	1.71
Other Current Liabilities	328.66	29.71	33.19	21.69	19.79	113.86
Total Current Liabilities	373.2	174.65	337.07	144.99	128.08	425.64
Long-Term Debt	376.07	373.59	-	323.84	386.69	300
Long-Term Leases	98.28	100.86	84.72	22.85	24.1	28.48
Pension & Post-Retirement Benefits	-	6.41	8.14	18.92	25.47	35.16
Long-Term Deferred Tax Liabilities	4.49	0.49	4.35	0.03	0.05	-
Other Long-Term Liabilities	40.01	33.35	23.15	23.03	22.91	22.78
Total Liabilities	892.04	689.35	457.43	533.67	587.31	812.06
Common Stock	748.28	748.28	717.92	677.1	661.9	661.9
Additional Paid-In Capital	960.31	960.31	844.08	700.34	648.26	638.12
Retained Earnings	151.59	272.47	335.25	249.73	201.61	150.72
Comprehensive Income & Other	-0.77	-0.82	-0.2	-0.66	-0.84	-0.86
Shareholders' Equity	1,859	1,980	1,897	1,627	1,511	1,450
Total Liabilities & Equity	2,751	2,670	2,354	2,160	2,098	2,262
Total Debt	484.57	485.13	224.24	347.91	411.99	633.09
Net Cash (Debt)	607.88	440.57	581.69	397.09	205.74	62.75
Net Cash Growth	-11.98%	-24.26%	46.49%	93.01%	227.89%	-31.96%
Net Cash Per Share	8.12	5.73	7.81	5.19	2.76	0.88
Filing Date Shares Outstanding	74.83	74.83	71.79	67.71	66.19	66.19
Total Common Shares Outstanding	74.83	74.83	71.79	67.71	66.19	66.19
Working Capital	1,154	1,253	829.35	858.92	752.95	499.6
Book Value Per Share	24.85	26.46	26.42	24.02	22.83	21.90
Tangible Book Value	1,858	1,979	1,895	1,624	1,508	1,446
Tangible Book Value Per Share	24.83	26.45	26.40	23.99	22.79	21.85
Land	-	4.73	4.73	4.73	4.73	9.5
Buildings	-	689.26	687.72	686.59	686.32	688.54
Machinery	-	1,031	926.47	909.63	896.45	891.02
Construction In Progress	-	17.68	20.57	3.5	4.62	0.77